USPTO serial 79227875
LIAISON MDX
Reviewed by CopyMark Law Group
Reg. 5658530Status 708Registered
- Filing date
- Status date
- Registration date
- Jan 22, 2019
- Examiner
- NEHMER, JASON ROBERT
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with LIAISON MDX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey B. Sladkus, Esq.
Jeffrey B. Sladkus, Esq. THE SLADKUS LAW GROUP1397 Carroll DriveAtlanta, GA 30318United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Diagnostic preparations for medical purposes; diagnostic materials in the nature of medical diagnostic reagents and assays for extraction, testing and analysis of bodily fluids, namely, extraction of viral nucleic acid, bacterial nucleic acid, stool DNA, blood DNA, and RNA, and for the extraction and isolation of blood cells; preparations for use in medical diagnostic tests; chemical preparations for testing blood for medical purposes; chemical preparations for testing blood for veterinary purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; chemicals for medical use for testing DNA; nucleic acid sequences for medical and veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reactants for medical diagnosis; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic substances for medical use; diagnostic substances for veterinary use; antiserums for diagnostic purposes; chemical test reagents for medical use; chemical test reagents for veterinary use; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for veterinary use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for pharmaceutical use; test strips for measuring blood glucose levels; medical diagnostic test strips; chemical diagnostic reagents for medical use for extracting, testing and analyzing body fluids, nucleic acids, DNA, RNA; chemical diagnostic reagents for medical use for extracting, isolating, testing and analyzing body fluids ] | SECTION 71 - CANCELLED | — |
| 009 | Scientific apparatus and instruments, namely, molecular biological [ and immunological ] testing systems, namely, [ microarray scanners, ] DNA [ and protein chips, ] kits for multiplex polymerase chain reaction (PCR) tests consisting primarily of optical and electronic apparatus for analyzing biological or biochemical samples, namely, [ electrophoresis apparatus, ] nucleic acid and [ protein sequencing apparatus, ] and polymerase chain reaction (PCR) thermal cyclers, including associated hardware and software therefor and also containing devices for removing, marking, applying and identifying biological or biochemical samples, pipettes, [ or cannulae; ] diagnostic testing apparatus for scientific and research testing of biological or biochemical samples, namely, electrophoresis apparatus, nucleic acid [ and protein sequencing apparatus,] and polymerase chain reaction (PCR) thermal cyclers; computer systems and software for collecting, storing, analysing and reporting biological information, and for sample tracking and managing projects, laboratory workflows and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; software for electronic medical and diagnostic apparatus; software, namely, databanks and computer programs containing algorithms for helping to make medical decisions or carry out research, for diagnostic and therapeutic applications; Computer hardware for medical and diagnostic tasks; devices for generating images for detecting, quantifying and linking biological or chemical molecules; laboratory instruments, [ namely, genome sequencers; ] devices for generating images, namely, [ fluorimeters used to register ] fluorescence signals and produce data | ACTIVE | — |
| 010 | [ Test kits for clinical medical use comprising test tubes, test plates and indicator diagrams for evaluating test results; apparatus for carrying out medical diagnoses, namely, fluorescence diagnostic apparatus and instruments used for the purpose of identifying infectious diseases and the severity thereof; diagnostic imaging apparatus for medical use; diagnostic lasers for medical use; medical and diagnostic devices, apparatus and equipment for molecular analysis; scanners for medical diagnosis; spectrum analyzers for use in medical diagnosis; Ultrasonic medical diagnostic apparatus being sources of ultrasonic fields for use in medical diagnosis; Magnetic apparatus being sources of magnetic fields for use in medical diagnosis; Electromagnetic medical diagnostic imaging apparatus being sources of electromagnetic fields for use in medical diagnosis; optical instruments for medical diagnostics; containers for disposal of medical instruments, namely, medical samples, syringes and plungers; Medical sampling vials of plastic or other materials for containing medical samples; Medical preparation vials of plastic or other materials for preparation of medical samples; diagnostic testing instruments for medical purposes, namely, electrical laboratory diagnostic instruments for the analysis of nucleic acids and proteins for medical use; diagnostic kits consisting primarily of electronic instruments for medical diagnosis and analysis of body fluids, tissues, biomolecules, DNA, antibodies, proteins, molecular material or cellular material; scientific apparatus for diagnostic testing of biological samples medical use; medical specimen cups ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named LIAISON MDX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 18, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 18, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 14, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 14, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 14, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 13, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 14, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jan 22, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 9, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 9, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 22, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 15, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 22, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 17, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 17, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 17, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 28, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 18, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 18, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 18, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 18, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 5, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 6, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 19, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 19, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 5, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 5, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |